Faculty of Dentistry
Cairo, Egypt
NCT Number: NCT07323693
To evaluate and compare the clinical effectiveness of a Bioactive Desensitizer Gel (which releases calcium and phosphate to form hydroxyapatite) versus a standard 5% Sodium Fluoride (NaF) Varnish in reducing cervical dentin hypersensitivity (CDH) in adult patients over a period of 6 months.
Looking for future studies?
Notify Me18 year–30 year
All sexes
Interventional
Not applicable
Cairo, Egypt
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A micro-brush applicator was saturated with the material (Predicta Bioactive Desensitizer Gel) and massaged it into the tooth for 30-40 secs. Using a rubbing motion was used to liquefy the gel and allow it to penetrate the surface
Time frame: Change from the Baseline, 1 week, 1 months, 3 months, 6 months
A VAS is a line that is 10 cm in length, the extremes of which represent the limits of pain, a patient may experience an external stimulus (The left endpoint designated no pain was marked as 0 and the right endpoint designated sever pain was marked as 10). Patients will be asked to place a mark on the 10 cm line that indicated their dentin hypersensitivity intensity
Time frame: Change from the Baseline, 1 week, 1 months, 3 months, 6 months
It was used to assess dentin hypersensitivity. A score of 0, 1, 2 or 3 was assigned 0 = no subject response to stimulus
Cairo University
Other
Clinical Efficacy of Using Bioactive Desensitizer Gel Versus Sodium Fluoride Varnish on Cervical Dentin Hypersensitivity in Adult Patients: A 6m Randomized Clinical Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07622043
Dentin Desensitizing Agents, Dentin Hypersensitivity
Schaan, Liechtenstein
View Trial DetailsNCT07113847
Dentin Desensitizing Agents, Dentin Hypersensitivity
Cairo, El Shorouk City, Egypt
View Trial DetailsNCT06872749
Dentin Desensitizing Agents, Dentin Sensitivity
Belém, Pará, Brazil
View Trial DetailsNCT06614764
Dentin Desensitizing Agents, Neurologic Manifestations
Belém, Pará, Brazil
View Trial Details